Epic Bio Announces Presentations at Upcoming Scientific and Medical Conferences
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Epic Bio, a biotechnology company developing therapies to modulate gene expression using compact, non-cutting dCas proteins, today announced presentations at two upcoming scientific and medical conferences. Keystone Symposia: Chromatin Architecture in Development and Human Health Poster Title: Discovery and engineering of hypercompact transcriptional modulators for robust...
